Adam Wilkinson

Name:	Adam Wilkinson
Affiliation:	University of Cambridge
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	12 Jan 2016, 1:10 a.m.

Public lists managed by Adam Wilkinson

Talks given by Adam Wilkinson

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

Talks organised by Adam Wilkinson

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Adam Wilkinson actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• Insights into mammalian hematopoiesis from comparative functional genomic
• Making Hematopoietic Stem Cells: Backwards and Sideways
• Identification of Regulatory Networks in HSCs and Their Immediate Progeny via Integrated Proteome, Transcriptome, and DNA Methylome Analysis
• Title to be confirmed
• Aberrant chromatin programming in AML
• Predictive Engineering of Cell Fate
• Opening up the stem cell niche for human and mouse hematopoietic stem cells
• Mimicking of the process of human erythropoiesis using in vitro culture; studies on red blood cell membrane assembly and also use of 3D scaffolds
• Hematopoietic stem cell formation in the embryo
• Clinical and Biological Impact of Flt3 mutations in Acute Leukaemia
• Aurora A kinase and RPS14: new players in the myeloproliferative neoplasms
• Targeting survival pathways in CML stem cell persistence and TKI-resistance
• Dnmt3a in Normal and Malignant Hematopoiesis
• Normal and leukaemic (AML) human stem/progenitor cells
• Regulation of Akt by the Sin1-mTOR complex in lymphocytes
• Familial thrombocytopenias with predisposition to leukemia: RUNX1 targets
• Engaging mechanisms of negative B cell selection to overcome drug-resistance in leukaemia
• Heterogeneity of hematopoietic stem and progenitor cell populations: implications for ageing and regeneration
• Of mice and men and Tasmanian devils; assembling reference genomes from single cells.
• 4D tracking of haematopoietic stem and progenitor cells in their bone marrow microenvironment
• Haematopoietic Stem Cells
• Emerging therapeutic strategies for treating the first molecular disease
• Bone marrow environment and platelet production
• Mutations in Epigenetic Modifiers in Myeloid Malignancies
• Forward genetic screening using patient CML cells identifies IKAROS as a myeloid tumour suppressor
• Molecular and cellular basis of disease initiation in myeloproliferative neoplasms
• Look Beyond the Target: How Lessons from Chronic Myeloid Leukaemia Can Improve Cancer Targeted Therapies